ArticleIndian journal of ophthalmology2026
Beyond CD4: Posterior segment findings and virologic-immunologic predictors in highly active antiretroviral therapy-naïve HIV patients.
Article in Indian journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo assess ocular findings in treatment-naïve people living with HIV (PLWH), focusing on posterior segment involvement, and to identify key virologic and immunologic predictors, including cytomegalovirus (CMV) retinitis and HIV-related retinopathy.
designProspective cross-sectional study.
methodsThis study included 124 treatment-naïve PLWH who were referred for ophthalmologic screening at the time of HIV diagnosis. All participants underwent a comprehensive ophthalmic examination. Demographic and clinical data were collected, along with key immunologic and virologic markers: CD4+ and CD8+ T-cell counts, CD4/CD8 ratio, and plasma viral loads for both HIV and CMV, all measured prior to initiation of antiretroviral therapy. The primary outcome was the identification of posterior segment involvement, specifically CMV retinitis and HIV-related retinopathy, in relation to CD4 count, CD4/CD8 ratio, and CMV plasma load.
resultsPosterior segment involvement was observed in 29% of patients, most commonly CMV retinitis. Univariate analysis showed significant associations with age, CD4 count, CD4/CD8 ratio, log₁₀HIV plasma load, and log₁₀CMV plasma load. Multivariate analysis revealed that log₁₀CMV plasma load remained the strongest independent predictor of posterior segment involvement (OR: 1.630, P = 0.003). CMV retinitis was significantly associated with log₁₀CMV plasma load ( P < 0.001), with a threshold of 44.5 IU/mL (log₁₀ = 1.6470) demonstrating high sensitivity (85.7%) and negative predictive value (97.8%). For a higher threshold of 1370 IU/mL (log₁₀ = 3.1294), specificity was higher (90.0%) with a positive predictive value of 47.6%. HIV-related retinopathy correlated inversely with CD4/CD8 ratio ( P = 0.030).
conclusionsEarly ophthalmologic screening is essential in PLWH with advanced immunosuppression. CMV DNA plasma load, CD4 count, and CD4/CD8 ratio are useful markers to identify patients at risk of vision-threatening complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.